| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.
|
Am J Hematol
|
2005
|
5.64
|
|
2
|
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.
|
Ann Intern Med
|
2004
|
4.05
|
|
3
|
The amyloidogenic V122I transthyretin variant in elderly black Americans.
|
N Engl J Med
|
2015
|
3.36
|
|
4
|
Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.
|
Arch Intern Med
|
2005
|
2.33
|
|
5
|
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
|
JACC Cardiovasc Imaging
|
2012
|
2.03
|
|
6
|
Prognostic significance of strain Doppler imaging in light-chain amyloidosis.
|
JACC Cardiovasc Imaging
|
2010
|
1.93
|
|
7
|
Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.
|
Eur J Nucl Med Mol Imaging
|
2014
|
1.91
|
|
8
|
Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis.
|
Circulation
|
2003
|
1.71
|
|
9
|
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis.
|
Clin Lymphoma
|
2003
|
1.69
|
|
10
|
Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.
|
Chest
|
2003
|
1.68
|
|
11
|
Diagnosis and management of cardiac sarcoidosis.
|
Prog Cardiovasc Dis
|
2010
|
1.46
|
|
12
|
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.
|
Blood
|
2004
|
1.38
|
|
13
|
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
|
Am Heart J
|
2009
|
1.20
|
|
14
|
Cardiovascular magnetic resonance in cardiac amyloidosis.
|
Circulation
|
2005
|
1.10
|
|
15
|
"Bendopnea" or "kamptopnea?": Some thoughts on terminology and mechanisms.
|
JACC Heart Fail
|
2014
|
1.09
|
|
16
|
Cardiac amyloidosis.
|
Circulation
|
2012
|
1.08
|
|
17
|
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
|
Am Heart J
|
2012
|
1.07
|
|
18
|
Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish.
|
Am J Physiol Heart Circ Physiol
|
2013
|
1.06
|
|
19
|
Current perspectives on cardiac amyloidosis.
|
Am J Physiol Heart Circ Physiol
|
2011
|
1.04
|
|
20
|
Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction.
|
J Am Soc Echocardiogr
|
2004
|
1.01
|
|
21
|
Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with disopyramide.
|
Circulation
|
2012
|
1.01
|
|
22
|
Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
|
Circulation
|
2014
|
1.00
|
|
23
|
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
|
Amyloid
|
2005
|
0.93
|
|
24
|
Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis.
|
Am J Cardiol
|
2002
|
0.92
|
|
25
|
Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature.
|
Dermatol Online J
|
2012
|
0.91
|
|
26
|
Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis.
|
Circulation
|
2002
|
0.91
|
|
27
|
Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity.
|
Basic Res Cardiol
|
2013
|
0.91
|
|
28
|
The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation.
|
Mayo Clin Proc
|
2004
|
0.91
|
|
29
|
Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure?
|
Am J Cardiol
|
2005
|
0.85
|
|
30
|
Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis.
|
Amyloid
|
2002
|
0.85
|
|
31
|
Severe hypercalcaemia mimicking acute myocardial infarction.
|
Clin Med
|
2009
|
0.84
|
|
32
|
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis.
|
Br J Haematol
|
2002
|
0.84
|
|
33
|
Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis.
|
Am J Cardiol
|
2005
|
0.83
|
|
34
|
Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]).
|
Am J Cardiol
|
2003
|
0.80
|
|
35
|
The diagnosis and typing of cardiac amyloidosis.
|
Amyloid
|
2003
|
0.79
|
|
36
|
Management of atrial fibrillation--radical reform or modest modification?
|
N Engl J Med
|
2002
|
0.78
|
|
37
|
Amyloid heart disease.
|
Br J Hosp Med (Lond)
|
2010
|
0.78
|
|
38
|
Ethnic disparity in intracranial hemorrhage among anticoagulated patients with atrial fibrillation: an answer in search of a question?
|
J Am Coll Cardiol
|
2007
|
0.77
|
|
39
|
Atrial fibrillation or sinus rhythm? Controversy and contradiction in quality of life outcomes.
|
J Am Coll Cardiol
|
2006
|
0.76
|
|
40
|
Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity.
|
EMBO Mol Med
|
2015
|
0.76
|
|
41
|
Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation.
|
J Am Coll Cardiol
|
2004
|
0.75
|
|
42
|
Driving and ventricular arrhythmia: a historical perspective.
|
J Am Coll Cardiol
|
2008
|
0.75
|
|
43
|
Letter by Falk regarding article, "An unusual heart failure: cardiac amyloidosis due to light chain myeloma".
|
Circulation
|
2011
|
0.75
|
|
44
|
Longitudinal strain imaging in light-chain cardiac amyloidosis: can it help to refine the approach to treatment?
|
J Am Coll Cardiol
|
2012
|
0.75
|
|
45
|
Clinical problem-solving. A heavy heart.
|
N Engl J Med
|
2010
|
0.75
|
|
46
|
Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis.
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.75
|
|
47
|
Pulmonary venous isolation for atrial fibrillation in severe systolic heart failure: more questions than answers?
|
Heart
|
2011
|
0.75
|
|
48
|
Dronedarone in high-risk permanent atrial fibrillation.
|
N Engl J Med
|
2012
|
0.75
|
|
49
|
V122I transthyretin variant in elderly black Americans.
|
N Engl J Med
|
2015
|
0.75
|
|
50
|
Cardiomyopathy: the importance of recognizing the uncommon diagnosis.
|
Prog Cardiovasc Dis
|
2010
|
0.75
|
|
51
|
Adenosine-induced ventricular flutter?
|
Am J Emerg Med
|
2003
|
0.75
|
|
52
|
Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
53
|
A transthyretin variant, Asp18Asn, associated with amyloid cardiomyopathy: a new African-American variant?
|
Amyloid
|
2012
|
0.75
|